Takuya Fukumi

Sparing Regulatory T Cells Disease by Inhibiting Effector T Cell Differentiation while ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Pretransplant Short-Term Exposure of Donor Graft Cells to

Y. Maeda, Ken-ichi, T. Kondo, 2021 .

Donor Treg expansion by liposomal α‐galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft‐versus‐host disease

Y. Ishii, Y. Maeda, T. Toji, 2021, Immunity, inflammation and disease.

Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression

D. Ennishi, Y. Ishii, S. Tomida, 2021, Scientific Reports.

Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab

D. Ennishi, Y. Maeda, K. Matsuoka, 2021, Leukemia.

Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells

Y. Maeda, K. Matsuoka, T. Kondo, 2021, ImmunoHorizons.

Hematopoietic stem cell–derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide

D. Ennishi, T. Matsushita, Y. Maeda, 2023, JCI insight.

Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome

K. Suzuki-Inoue, K. Fujii, N. Fujii, 2024, Internal medicine.